Press Releases :: OPKO Health, Inc. (OPK)

Labcorp Enters into Agreement with OPKO Health to Acquire Select Assets of BioReference Health

Read the news release

Visit BioReference Health

Year

Category

Feb 8, 2017 8:00 am EST

OPKO Spain to Start Trial of Once-A-Year Intra-Articular Injectable for Osteoarthritis

Feb 7, 2017 8:00 am EST

OPKO Health Promotes Thomas Nusbickel to Renal Division Chief Commercial Officer

Feb 1, 2017 8:30 am EST

OPKO’S GeneDx Announces Research Collaboration with the Wellcome Trust Sanger Institute

Jan 10, 2017 8:30 am EST

OPKO Investee Zebra Biologics Announces Collaboration with AbbVie to Discover New Antibody Therapeutics

Jan 9, 2017 1:31 pm EST

OPKO Announces Initiation of Claros® 1 Clinical Trial for Total PSA

Jan 4, 2017 8:30 am EST

OPKO Health to Present at the J.P. Morgan 35th Annual Healthcare Conference

Dec 30, 2016 8:25 am EST

OPKO Health Provides Update on hGH-CTP Clinical Programs

Dec 19, 2016 9:00 am EST

OPKO Health to be Added to the NASDAQ Biotechnology Index

Nov 30, 2016 8:00 am EST

OPKO Health to Participate at Three Investment Conferences in December

Nov 23, 2016 11:31 am EST

OPKO Announces U.S. Launch of RAYALDEE™